Cargando…
Fetal and Neonatal Endocrine Disruptors
Endocrine disruptors are substances commonly encountered in every setting and condition in the modern world. It is virtually impossible to avoid the contact with these chemical compounds in our daily life. Molecules defined as endocrine disruptors constitute an extremely heterogeneous group and incl...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386773/ https://www.ncbi.nlm.nih.gov/pubmed/22672860 http://dx.doi.org/10.4274/Jcrpe.569 |
_version_ | 1782237023186190336 |
---|---|
author | Ünüvar, Tolga Büyükgebiz, Atilla |
author_facet | Ünüvar, Tolga Büyükgebiz, Atilla |
author_sort | Ünüvar, Tolga |
collection | PubMed |
description | Endocrine disruptors are substances commonly encountered in every setting and condition in the modern world. It is virtually impossible to avoid the contact with these chemical compounds in our daily life. Molecules defined as endocrine disruptors constitute an extremely heterogeneous group and include synthetic chemicals used as industrial solvents/lubricants and their by-products. Natural chemicals found in human and animal food (phytoestrogens) also act as endocrine disruptors. Different from adults, children are not exposed only to chemical toxins in the environment but may also be exposed during their intrauterine life. Hundreds of toxic substances, which include neuro-immune and endocrine toxic chemical components that may influence the critical steps of hormonal, neurological and immunological development, may affect the fetus via the placental cord and these substances may be excreted in the meconium. Children and especially newborns are more sensitive to environmental toxins compared to adults. Metabolic pathways are immature, especially in the first months of life. The ability of the newborn to metabolize, detoxify and eliminate many toxins is different from that of the adults. Although exposures occur during fetal or neonatal period, their effects may sometimes be observed in later years. Further studies are needed to clarify the effects of these substances on the endocrine system and to provide evidence for preventive measures. Conflict of interest:None declared. |
format | Online Article Text |
id | pubmed-3386773 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-33867732012-07-09 Fetal and Neonatal Endocrine Disruptors Ünüvar, Tolga Büyükgebiz, Atilla J Clin Res Pediatr Endocrinol Review Endocrine disruptors are substances commonly encountered in every setting and condition in the modern world. It is virtually impossible to avoid the contact with these chemical compounds in our daily life. Molecules defined as endocrine disruptors constitute an extremely heterogeneous group and include synthetic chemicals used as industrial solvents/lubricants and their by-products. Natural chemicals found in human and animal food (phytoestrogens) also act as endocrine disruptors. Different from adults, children are not exposed only to chemical toxins in the environment but may also be exposed during their intrauterine life. Hundreds of toxic substances, which include neuro-immune and endocrine toxic chemical components that may influence the critical steps of hormonal, neurological and immunological development, may affect the fetus via the placental cord and these substances may be excreted in the meconium. Children and especially newborns are more sensitive to environmental toxins compared to adults. Metabolic pathways are immature, especially in the first months of life. The ability of the newborn to metabolize, detoxify and eliminate many toxins is different from that of the adults. Although exposures occur during fetal or neonatal period, their effects may sometimes be observed in later years. Further studies are needed to clarify the effects of these substances on the endocrine system and to provide evidence for preventive measures. Conflict of interest:None declared. Galenos Publishing 2012-06 2012-06-09 /pmc/articles/PMC3386773/ /pubmed/22672860 http://dx.doi.org/10.4274/Jcrpe.569 Text en © Journal of Clinical Research in Pediatric Endocrinology, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Ünüvar, Tolga Büyükgebiz, Atilla Fetal and Neonatal Endocrine Disruptors |
title | Fetal and Neonatal Endocrine Disruptors |
title_full | Fetal and Neonatal Endocrine Disruptors |
title_fullStr | Fetal and Neonatal Endocrine Disruptors |
title_full_unstemmed | Fetal and Neonatal Endocrine Disruptors |
title_short | Fetal and Neonatal Endocrine Disruptors |
title_sort | fetal and neonatal endocrine disruptors |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386773/ https://www.ncbi.nlm.nih.gov/pubmed/22672860 http://dx.doi.org/10.4274/Jcrpe.569 |
work_keys_str_mv | AT unuvartolga fetalandneonatalendocrinedisruptors AT buyukgebizatilla fetalandneonatalendocrinedisruptors |